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EGF regulates magnesium renal 
excretion
Magnesium is a critical ion in a large number of cellular metabolic 
reactions as well as a regulator of parathyroid hormone release 
and action. Although magnesium deﬁciency aﬀects multiple body 
functions, its symptoms are mostly related to muscle dysfunction-
ing, such as tetany, prolonged QT interval, and cardiac arrhyth-
mias. Magnesium deﬁciency can be secondary to systemic diseases 
(for instance, diabetes mellitus), or to the use of osmotic agents, 
diuretics, and drugs such as cyclosporin and cisplatin. In response 
to altered magnesium uptake by the intestine, magnesium plasma 
concentration is maintained within a narrow range by changes 
in its urinary excretion. Most renal reabsorption of magnesium 
occurs in the proximal tubule and the thick ascending limb of 
the loop of Henle via a passive paracellular transport process. But 
the ﬁne-tuning of magnesium excretion takes place in the distal 
convoluted tubule, where the ion is reabsorbed via an active trans-
cellular transport process. Apical magnesium entry into cells of 
the distal convoluted tubule is mediated by a magnesium channel, 
TRPM6, and driven by a favorable transmembrane voltage. How-
ever, the mechanism of basolateral magnesium transport into the 
interstitium is unknown, and the exact mechanisms of transepi-
thelial magnesium transport remain obscure. Primary magnesium 
deﬁciency is observed in several monogenetic disorders; analysis 
of these cases has provided insight into the molecular and cellular 
mechanisms that underlie magnesium (re)absorption. For exam-
ple, genetic studies in families with hereditary renal magnesium 
wasting have identiﬁed several genes that are either directly or 
indirectly involved in active magnesium handling, for example, 
thiazide-sensitive sodium chloride cotransporter, the γ subunit of 
the Na,K-ATPase, and the magnesium channel TRPM6.
To elucidate the gene defect and molecular mechanism underly-
ing isolated recessive renal hypomagnesemia (IRH), Groenestege 
et al. used a homozygosity-based mapping strategy and mutation 
detection. They discovered that IRH was due to a mutation in the 
EGF gene. Immunohistochemistry on kidney sections showed 
that EGF was consistently coexpressed with the thiazide-sensitive 
sodium chloride cotransporter, a marker of the distal convoluted 
tubule (Figure). The EGF mutation caused impaired basolateral 
sorting of the pro-peptide (pro-EGF). As a consequence, the pep-
tide receptor in the kidney (EGFR) was inadequately stimulated, 
resulting in insuﬃcient activation of the epithelial magnesium 
channel TRPM6 and magnesium loss in the urine. In addition, 
the authors found that patients with colorectal cancer treated 
with cetuximab, an antagonist of the EGFR, developed hypomag-
nesemia. Thus, EGF was found to be a magnesiotropic hormone 
crucial for maintenance of body magnesium balance. (J Clin Invest 
2007; 117: 2260–2267)
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Endothelial cells participate in 
cardiac fibrosis
A morphological lesion found in some forms of heart failure 
is cardiac ﬁbrosis, which seems to follow a pathway similar 
to that of ﬁbrosis in other epithelial organs, such as the liver, 
kidney, lung, skin, and solid tumors. The predominant cellu-
lar mediators are thought to be ﬁbroblasts; however, the origin 
of the ﬁbroblasts during adult cardiac ﬁbrosis is unclear. Adult 
ﬁbroblasts increase in number as a result of the proliferation of 
resident ﬁbroblasts. But recent studies have shown that during 
ﬁbroblast proliferation, epithelial cells contribute to ﬁbroblast 
accumulation through an epithelial–mesenchymal transition 
(EMT).
During cardiac embryonic development, a form of EMT is 
the endothelial–mesenchymal transition (EndMT). Zeisberg 
et al. hypothesized that EndMT might contribute to the accu-
mulation of cardiac fibroblasts during cardiac fibrosis, reca-
pitulating pathways associated with cardiac development. They 
used Tie1Cre;R26RstoplacZ mice, in which cells of endothe-
lial origin were irrevocably marked by lacZ expression, and 
FSP1-GFP transgenic mice, in which green ﬂuorescent protein 
was expressed under the control of the promoter of ﬁbroblast- 
specific protein 1. During cardiac fibrosis, endothelial cells 
underwent EndMT and contributed to the total pool of cardiac 
ﬁbroblasts. Transforming growth factor-β1 (TGFβ1), a promoter 
of cardiac ﬁbrosis, induced EndMT in adult coronary endothelial 
cells, whereas rhBMP-7 preserved the endothelial phenotype and 
reversed TGFβ1-induced EndMT (Figure). In addition, TGFβ1-
induced cardiac ﬁbrosis was impaired in mice heterozygous for the 
EGF (green) and thiazide-sensitive sodium chloride cotransporter (red) 
in rat kidney sections. EGF colocalized with Na-Cl cotransporter, a marker 
for the distal convoluted tubule.
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Treatment with rhBMP-7 inhibits cardiac fibrosis and reduces EndMT in  
a model of chronic rejection.
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transcription factor Smad3. Systemic administration of rhBMP-7 
signiﬁcantly reduced the number of ﬁbroblasts and improved heart 
function. These results are the ﬁrst to demonstrate that EndMT 
occurs in an adult tissue and contributes to the progression of 
cardiac ﬁbrosis. Also, these studies show that rhBMP-7 may be a 
useful therapeutic agent in heart ﬁbrosis, and they open new lines 
of inquiry into the pathogenesis of ﬁbrosis in other organs. (Nat 
Med 2007; 13: 952–961)
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A new mechanism of proteinuric 
kidney disease
The glomerular basement membrane (GBM), glomerular 
endothelial cells, and podocytes are the key components of the 
glomerular permeability barrier. Podocytes form foot proc-
esses, highly dynamic cellular extensions, which are connected 
by slit diaphragms. Most forms of proteinuria are characterized 
by a reduction in the number and size of podocyte membrane 
extensions, as well as transformation of podocyte foot processes 
into a band of shapeless cytoplasm (referred to as foot process 
eﬀacement). Although in a small number of cases proteinuria 
and foot process eﬀacement are due to genetic mutations, these 
mutations do not explain the molecular mechanisms underly-
ing the far more common sporadic cases. Lysosomal cathepsins 
(cathepsin L), one of a subclass of cysteine proteases that are 
involved primarily in protein breakdown within the lysosomal 
compartment, were found to be strongly induced in rodent 
nephrotic podocytes. Other studies also show that inhibitors 
of cysteine proteases reduced proteinuria in rats, perhaps by 
inhibiting degradation of the GBM.
In a recent publication, Sever et al. examined cathepsin L 
mRNA levels using quantitative real-time PCR in microdis-
sected glomeruli from patients with acquired proteinuric dis-
eases. They found that CatL mRNA levels were at least twofold 
greater than those of controls in samples from patients with 
three types of proteinuric kidney diseases—membranous 
glomerulonephritis, focal segmental glomerulosclerosis, and 
diabetic nephropathy. In addition, they found that staining for 
cathepsin L increased in the glomeruli of patients with diabetic 
nephropathy (Figure). They next identiﬁed that a target of cathe-
psin L was dynamin, a large GTPase essential for the formation 
of clathrin-coated vesicles at the plasma membrane that has 
been implicated in the regulation of actin dynamics in some 
cells. If cleavage of dynamin by cathepsin causes proteinuria, 
it must be essential for podocyte morphology and function in 
healthy kidneys. To test this, they expressed a dominant-nega-
tive dynK44A in mouse podocytes and found that it caused severe 
proteinuria and foot process eﬀacement. This important study 
shows that dynamin is required to maintain the ultraﬁltration 
barrier in kidneys (possibly via regulation of the actin cytoskel-
eton in podocytes), and that cleavage of dynamin by cathepsin 
L leads to podocyte failure and proteinuria. These results deﬁne 
a new role for cathepsin L and dynamin in the pathogenesis 
of glomerular proteinuria and open new potential avenues for 
pharmacological intervention in proteinuric kidney disease. 
(J Clin Invest 2007; 117: 2095–2104)
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Dietary salt intake and blood pH
Salt consumed in excessive amounts contributes to the cur-
rent epidemics of hypertension and cardiovascular disease. Salt 
intake is a major determinant of extracellular ﬂuid volume and 
extracellular ﬂuid volume inﬂuences acid–base homeostasis. In 
general, Western diets produce net acid and induce a low-grade 
metabolic acidosis proportional to the diet net acid load. It has 
been shown that adding excess oral sodium chloride (NaCl) to 
a net base-producing diet for several days slightly increased the 
blood hydrogen ion concentration (that is, decreased pH). In 
a recent publication, Frassetto et al. examined whether the Cl 
content in the diet inﬂuences the amount of metabolic acidosis 
in healthy subjects. In 77 subjects, dietary Cl was found to be an 
independently positive and negative predictor, respectively, of 
[H+] in blood and plasma [HCO3
–]. Plasma [HCO3
–] decreased 
by 1.2 mequiv./liter per 100 mequiv./day increase in urinary 
chloride excretion. In other words, increasing the dietary NaCl 
was independently associated with increasing amounts of meta-
bolic acidosis. If these associations reﬂect causal eﬀects of die-
tary NaCl, NaCl loads would have between 50% and 100% of the 
diet net acid load acidosis-producing eﬀect. Thus, the amount 
of NaCl in a net acid-producing diet independently predicts 
the degree of hyperchloremic metabolic acidosis. Changes in 
extracellular volume have so many eﬀects that it is diﬃcult to 
identify the exact mechanism responsible for these observa-
tions. However, regardless of the mechanism, the authors state 
that there may be pathophysiological consequences of dietary 
NaCl-induced metabolic acidosis. For example, in studies with 
the DASH diet, low sodium intake improved bone turnover. 
Also, dietary salt increases the risk of kidney stones. Salt load-
ing not only reduced serum bicarbonate concentration and 
urinary citrate excretion but also increased urinary saturation 
of calcium phosphate and monosodium urate. These observa-
tions suggest that excess salt intake may have more adverse side 
eﬀects than previously thought. (Am J Physiol Renal Physiol 
2007; 293: F521–F525)
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CatL labeling of a normal human kidney (left panel) and CatL labeling of a 
human kidney with diabetic nephropathy (right panel). 
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